Yahoo
Shanghai - Delayed Quote CNY

APT Medical Inc. (688617.SS)

274.98 +2.98 (+1.10%)
At close: 3:00:02 PM GMT+8
Chart Range Bar
Loading chart for 688617.SS
  • Previous Close 272.00
  • Open 271.50
  • Bid 274.98 x --
  • Ask 274.99 x --
  • Day's Range 269.45 - 278.97
  • 52 Week Range 176.28 - 293.50
  • Volume 2,052,857
  • Avg. Volume 1,633,784
  • Market Cap (intraday) 38.918B
  • Beta (5Y Monthly) -0.33
  • PE Ratio (TTM) 37.88
  • EPS (TTM) 7.26
  • Earnings Date --
  • Forward Dividend & Yield 1.00 (0.37%)
  • Ex-Dividend Date May 14, 2026
  • 1y Target Est 349.41

APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. It offers electrophysiology products, such as navigation systems, navigated catheters, mapping catheters, ablation catheters, transseptal needles and sheaths, and steerable sheaths; and interventional cardiology and peripheral products, including access, diagnostic products, therapeutic products, and accessories. The company also manufactures and supplies EP and vascular intervention medical devices. In addition, it provides OEM and ODM services comprising project design and development, customization, and volume OEM; and customized products consisting of catheters, guidewires, and delivery systems, as well as nitinol products in cardiology, peripheral, neurology, and urology. APT Medical Inc. was founded in 2002 and is headquartered in Shenzhen, China.

www.aptmed.com

3,118

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

688617.SS
13.50%
SSE Composite Index (000001.SS)
8.34%

1-Year Return

688617.SS
0.04%
SSE Composite Index (000001.SS)
8.01%

3-Year Return

688617.SS
65.26%
SSE Composite Index (000001.SS)
20.89%

5-Year Return

688617.SS
104.89%
SSE Composite Index (000001.SS)
3.78%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 831.66M
Earnings 280.89M
Profit Margin 33.78%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
200M
400M
600M
800M
0.0%
10.0%
20.0%
30.0%

Analyst Insights

View More

Analyst Price Targets

318.00
349.41 Average
274.98 Current
399.44 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    33.03%

  • Return on Assets (ttm)

    18.69%

  • Return on Equity (ttm)

    30.97%

  • Revenue (ttm)

    3.07B

  • Net Income Avi to Common (ttm)

    1.02B

  • Diluted EPS (ttm)

    7.26

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.79B

  • Total Debt/Equity (mrq)

    0.35%

  • Levered Free Cash Flow (ttm)

    782.34M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: